Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kent W Mouw

Showing results (51-60 of 121) with videos related to

Pageof 13
Sort By:
Biorxiv : the Preprint Server for Biology|March 10, 2025
Tumor B cell infiltration in platinum-treated advanced urothelial carcinomaKonrad Stawiski, Júlia Perera-Bel, Alejo Rodriguez-Vida, et al.
Molecular Oncology|June 2, 2026
Tumor B-cell infiltration in platinum-treated advanced muscle-invasive urothelial carcinomaKonrad Stawiski, Júlia Perera-Bel, Alejo Rodriguez-Vida, et al.
Clinical Genitourinary Cancer|September 8, 2020
Development and Validation of a Novel TP53 Mutation Signature That Predicts Risk of Metastasis in Primary Prostate CancerFallon E Chipidza, Mohammed Alshalalfa, Brandon A Mahal, et al.
Oral Oncology|May 25, 2012
Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapyKent W Mouw, Abhishek A Solanki, Kerstin M Stenson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2018
Mutational Analysis of 472 Urothelial Carcinoma Across Grades and Anatomic SitesAmin H Nassar, Renato Umeton, Jaegil Kim, et al.
Urology|August 9, 2020
Three-tiered Subclassification System of High-risk Prostate Cancer in Men Managed With Radical Prostatectomy: Implications for Treatment Decision-makingNayan Lamba, Santino Butler, Brandon A Mahal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2019
Practice Patterns and Outcomes Among Patients With N0M0 Prostate Cancer and a Very High Prostate-Specific Antigen LevelVinayak Muralidhar, Paul L Nguyen, Brandon A Mahal, et al.
Urologic Oncology|January 26, 2023
Bladder preservation after neoadjuvant therapy - 2021 IBCN updates part 1Patrick J Hensley, Roland Seiler, Harry Herr, et al.
Genome Research|November 22, 2018
Quantification of somatic mutation flow across individual cell division events by lineage sequencingYehuda Brody, Robert J Kimmerling, Yosef E Maruvka, et al.
Urology|April 15, 2021
Clinical characterization of radiation-associated muscle-invasive bladder cancerSybil T Sha, Edward Christopher Dee, Matthew Mossanen, et al.
Pageof 13

Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
Biorxiv : the Preprint Server for Biology|March 10, 2025
Tumor B cell infiltration in platinum-treated advanced urothelial carcinomaKonrad Stawiski, Júlia Perera-Bel, Alejo Rodriguez-Vida, et al.
Molecular Oncology|June 2, 2026
Tumor B-cell infiltration in platinum-treated advanced muscle-invasive urothelial carcinomaKonrad Stawiski, Júlia Perera-Bel, Alejo Rodriguez-Vida, et al.
Clinical Genitourinary Cancer|September 8, 2020
Development and Validation of a Novel TP53 Mutation Signature That Predicts Risk of Metastasis in Primary Prostate CancerFallon E Chipidza, Mohammed Alshalalfa, Brandon A Mahal, et al.
Oral Oncology|May 25, 2012
Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapyKent W Mouw, Abhishek A Solanki, Kerstin M Stenson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2018
Mutational Analysis of 472 Urothelial Carcinoma Across Grades and Anatomic SitesAmin H Nassar, Renato Umeton, Jaegil Kim, et al.
Urology|August 9, 2020
Three-tiered Subclassification System of High-risk Prostate Cancer in Men Managed With Radical Prostatectomy: Implications for Treatment Decision-makingNayan Lamba, Santino Butler, Brandon A Mahal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2019
Practice Patterns and Outcomes Among Patients With N0M0 Prostate Cancer and a Very High Prostate-Specific Antigen LevelVinayak Muralidhar, Paul L Nguyen, Brandon A Mahal, et al.
Urologic Oncology|January 26, 2023
Bladder preservation after neoadjuvant therapy - 2021 IBCN updates part 1Patrick J Hensley, Roland Seiler, Harry Herr, et al.
Genome Research|November 22, 2018
Quantification of somatic mutation flow across individual cell division events by lineage sequencingYehuda Brody, Robert J Kimmerling, Yosef E Maruvka, et al.
Urology|April 15, 2021
Clinical characterization of radiation-associated muscle-invasive bladder cancerSybil T Sha, Edward Christopher Dee, Matthew Mossanen, et al.
Pageof 13